Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BPBIO750

K-Number: K231174 · 2023-08-02

Decision Date2023-08-02
Product CodeDXN
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

BPBIO750 is a medical device manufactured by Inbody Co., Ltd.. It received FDA 510(k) clearance on 2023-08-02 under approval number K231174. The device is classified under product code DXN. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BPBIO750?

BPBIO750 is a medical device that received FDA 510(k) clearance on 2023-08-02. It is manufactured by Inbody Co., Ltd.. The 510(k) number is K231174.

When was BPBIO750 approved by the FDA?

BPBIO750 received FDA 510(k) clearance on 2023-08-02, under approval number K231174.

What company makes BPBIO750?

BPBIO750 is manufactured by Inbody Co., Ltd..

What is the FDA product code for BPBIO750?

The FDA product code for BPBIO750 is DXN.

Other Devices by Inbody Co., Ltd.

Related Devices (Code: DXN)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.